Shattuck Labs (STTK) Change in Account Payables (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Change in Account Payables of -$911000.0 for Q1 2026, down 2.82% year-over-year from -$937451.8 in Q1 2025, and down 197.02% quarter-over-quarter from $939000.0 in Q4 2025.
Shattuck Labs (STTK) Change in Account Payables (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Change in Account Payables for 8 consecutive years, with -$911000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Account Payables fell 2.82% year-over-year to -$911000.0; the TTM figure through Mar 2026 stood at -$343000.0 (up 64.27% YoY), while the FY2025 annual figure was -$318000.0, down 138.22% from the prior year.
- Change in Account Payables fell to -$911000.0 in Q1 2026 per STTK's latest filing, from $939000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $4.4 million in Q4 2022 and bottomed at -$7.7 million in Q1 2022.
- Historically, Change in Account Payables has averaged -$521647.1 across 5 years, with a median of -$475000.0 in 2023.
- Annual changes were most pronounced in 2022 — Change in Account Payables slumped 723.53% — and 2025, when it surged 497.39%.
- Shattuck Labs' Change in Account Payables stood at $4.4 million in 2022, then plunged by 110.91% to -$475000.0 in 2023, then retreated by 6.95% to -$508000.0 in 2024, then surged by 284.84% to $939000.0 in 2025, then plunged by 197.02% to -$911000.0 in 2026.
- Business Quant data shows STTK's Change in Account Payables at -$911000.0 in Q1 2026, $939000.0 in Q4 2025, and $687000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Shattuck Labs | 962.96 Mn | 962.96 Mn | - | 2.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.52 Mn |
| Jun 30, 2026 | 2.52 Mn |
| Mar 31, 2026 | -911,000.00 |
| Mar 31, 2026 | -911,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Dec 31, 2025 | 939,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Sep 30, 2025 | 687,000.00 |
| Jun 30, 2025 | -1.06 Mn |
| Jun 30, 2025 | -1.06 Mn |
| Mar 31, 2025 | -886,000.00 |
| Mar 31, 2025 | -886,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Dec 31, 2024 | -508,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 906,000.00 |
| Mar 31, 2024 | 906,000.00 |